Three other stage III patients, who suffered recurrence within one year after surgery and died after the first recurrence (survival <4 years), were also positive for p53 protein in their tumor cells, but the expression of RPS27L protein was weak at the corresponding positions (Figure 1B, patients 4–6). This evidence concerns the gene TP53 and neoplasm.